Proton-Pump Inhibitors (PPIs) for Gastro-oesophageal reflux disease (GORD) in paediatric patients. BSWformulary options
omeprazole suspension dispersible esomeprazole lansoprazole
APC
Oxford Health Guideline for the Treatment of Depression in Children and Adolescents – approved for BSW
paediatric citalopram escitalopram fluoxetine sertraline
Guidance to support the continued prescribing of SSRIs in primary care in <18-year-olds for the treatment of depression - approved for BSW
children paediatric citalopram escitalopram fluoxetine sertraline
APC Recent Decisions June/July 2022
calcipotriol wynzora tafluprost infliximab dementia donepezil galantamine memantine rivastigmine acenocoumarol sinthrone insulin
BSW Insulin Formulary
Diabetes Lantus Abasaglar levemir tresiba Trurapi apidra novorapid humalog fiasp lyumjey isuman basal humulin insulman rapid insuman comb 25 insuman comb 50 humulin m3 novomix… Read More »BSW Insulin Formulary
AWP Procedure for Monitoring Psychotropic Medication – a guide to essential tests and investigations
antipsychoticmonitorlithiumcarbamazepinehaloperidololanzapineclozapinevalproatevalproic acidlamotrigineantidepressantscitalopramescitaloprammirtazapineduloxetinevenlafaxineagomelatinearipiprazolerisperidonequetiapine
Acenocoumarol Information for Healthcare Professionals
simthrome warfarin INR
APC Recent Decisions May 2022
acenocoumarol sinthrone guanfacine intuniv somatropin saizen easypod liothyronine testosterone testogel empagliflozin dapagliflozin heart failure HF anticoagulation NVAF atrial fibrillation AF edoxaban DOAC nutrition food first… Read More »APC Recent Decisions May 2022
Anticoagulation in non-valvular atrial fibrillation (NVAF): BSW Guidance for Prescribers
Anticoagulation anticoagulant nvaf atrial fibrillation af doac noac edoxaban apixaban rivaroxaban dabigatran eliquis lixiana xarelto Pradaxa switching IIF